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Abstract 
This dissertation was written as part of the MSc in in Bioeconomy Law, Regulation and 
Management at the International Hellenic University.  
Antimicrobial resistant bacteria are of public health concern, since they can be 
biological hazards linked to increased human mortality and morbidity. Use of 
antimicrobials for control and treatment of infectious diseases in livestock and crops 
goes on due to considerations with respect to animal health and welfare, and also 
plant health. As a result, the dissemination of antimicrobial resistance by transfer of 
bacteria or genes from animals or plants to humans through the food chain is a public 
health issue of major concern. The dissemination of antimicrobial resistant bacteria 
and resistance genes to humans via food can follow several different routes and 
mechanisms, by foodborne spread of: i) resistant zoonotic bacteria, ii) resistant non-
zoonotic human pathogenic bacteria and iii) commensal bacteria that exhibit 
resistance due to transferable antimicrobial resistance genes. Risk assessment is a 
scientific tool that its purpose is to provide risk managers with a rational and objective 
picture of what is known, or believed, at a particular time. Risk assessment can be 
quantitative or qualitative with the process being essentially similar since both 
procedures involve identification of the risk pathway, collection of data and risk 
evaluation. Qualitative risk assessment provides a rough estimate of risk, using 
definitions like high, medium and low risk and uses all relevant data (including 
numerical data) in order to reach a inference. The aim of this dissertation is to identify 
the principles of risk assessment for antimicrobial resistance occurring in the food 
pathway; to identify i) the qualitative risks, ii) the direct and indirect hazards, iii) the 
pathways of exposure; to summarize data in order to evaluate size of the hazard to 
which humans are exposed, and to assess the further consequences of resistance. 
Keywords: risk assessment, antimicrobial resistance, resistance genes, hazard, 
foodborne. 
Panagiota Gousia 
Thessaloniki, 14 December 2018 
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1. Introduction and Definitions  
Antimicrobial resistance (AMR) is no longer just a potential threat; it is a serious health 
problem that is rapidly increasing across the world (Butaye et al, 2015). This is a major 
global public health concern and a food safety issue since pathogens can become 
resistant to antimicrobial agents and pose a greater human health risk. The threat to 
human health consists of potential treatment failure due to inappropriate 
antimicrobials, lack of treatment choices and increased harshness of disease (O Neil, 
2016). 
A resistant bacterium is the one that can stand higher concentrations of an 
antibiotic than other, phenotypically related bacteria of the original or “wild type” 
strain (EFSA, 2008). Such strains usually differ phenotypically from the wild type. Not 
only that they usually have acquired a resistance mechanism by gene transfer or by 
mutation (acquired resistance). 
Acquired resistance. There are two mechanisms by which a bacterial isolate can 
acquire resistance: mutation or acquisition of exogenous genes by horizontal transfer 
from other bacterial strains. The genes that encode the enzymes responsible for the 
modification of the structure of an antimicrobial and therefore the tolerance of the 
bacterium to it, can be easily transferred. Such transferable genes are the ones 
encoding penicillinases and cephalosporinases (bla genes), acetyl transferases 
responsible for aminoglycoside modification (aac genes), genes that can lead to 
modification of the antibiotic target (erm-genes), methicillin resistance (mecA genes) 
and resistance to glycopeptides (van genes). 
Cross resistance. Since antimicrobials are a quite diverse group of molecules, 
they are classified in classes that usually categorize substances with similar structure 
and mode of action. It is not uncommon that the antibiotics in each class share a 
common target in the bacterial cell and a similar mode of action. Therefore, resistance 
to a antimicrobial usually is accompanied by variable resistance to the other 
antimicrobials of its class.  
Corresistance. The resistance genes are often organized in larger genetic 
elements that can be transposons, integrons or plasmids. Since they are gathered in 
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these structures, unrelated resistance genes are co-acquired resulting to resistance in 
phenotypically unrelated traits. Therefore, a single transfer of e.g. a plasmid can result 
to transfer of several resistance genes. The term corresistance is therefore used when 
two or more different resistance genes are physically related (EFSA, 2008). 
Multiple resistance. Multiple resistance is the term used to declare that a 
bacterium is resistant to more than two different antimicrobial classes. Quite often it is 
also used to describe a strain resistant to more than two antimicrobials, but due to 
possible cross resistance this definition is less accurate. The references to the 
definition vary considerably, making the use of this term quite problematic. 
Antimicrobial resistance genes. Genes in bacteria conferring resistance to 
antibiotics. They are usually located on mobile genetic elements, and because of that 
they have the ability of horizontal transmission from resistant to susceptible strains. 
Empirical therapy. Therapy introduced on the basis of observation of clinical 
symptoms and patient’s history, without verification of diagnosis by laboratory 
diagnostic methods. 
Hazard. A physical, chemical or biological agent in food potential to cause an 
adverse health effect. 
Risk. A function of the likelihood of a harmful effect and the importance of that 
effect, resulting to hazard in food. 
Risk Analysis. A process consisting of risk assessment, risk management and risk 
communication. 
Antimicrobial resistance has been linked to use of antibiotics in almost any 
environment. Antibiotics are used for human and non-human purposes. A not much 
sought risk factor is the use of antibiotics in food animals. In addition, their use in 
agriculture has been also neglected since they can contribute to selection and spread 
of antimicrobial resistant microorganisms. Both food producing animals and farming 
can introduce resistant bacteria or genes in the food chain and unavoidably to humans 
(Anonymous, 2011). 
Transmission of resistant bacterial cells to humans and especially to human 
gastrointestinal tract is of importance due to either direct infections or the likelihood 
of horizontal gene exchange with other, potentially pathogenic members of the gut 
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microbiota promoted by the high number of cells found in the gut (Aarestrup et al., 
2008; Collignon et al., 2016).  
Risk assessment. The scientific analytical process to evaluate the chance of 
adverse effects from exposure to a hazard such as physical, chemical or biological 
agent) or hazardous event (Claycamp, 2015). 
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2. Antimicrobial resistance in food 
Antimicrobial resistance in commensal, opportunistic bacteria or obligate pathogens is 
an increasing public health concern due to the likelihood of antimicrobial resistance 
gene transfer from commensal bacteria to pathogens or between pathogenic bacteria 
(Friedman, 2015;). Food stuff occupies a serious role in the transmission of both 
commensals and foodborne pathogens. Transmission of commensal microorganisms 
among food and humans happens during handling of raw products; during cross 
contamination and recontamination between different food materials at different 
stages of the food supply chain (Macdonald et al., 2015). A food supply chain refers to 
the processes which describe how food from a farm ends up on our tables (production, 
processing, distribution, household levels e.g. consumption and disposal). 
Transmission of antimicrobial resistant bacteria to humans and especially to the 
human gut is a matter of interest due to direct infections but also due to the chance of 
horizontal transfer of genes to other pathogenic members of the gut microbiome 
(Haug et al., 2011; Collignon et al., 2016).  
Various European countries carry out surveillance programs for antimicrobial 
resistance like Anresis in Switzerland, Swedres Svarm in Sweden, DANMAP in Denmark 
(Danmap, 2014; Swedres-Svarm, 2015). Data from European countries are further 
collected, organized and evaluated under the umbrella of the European Centre for 
Disease Control (ECDC) and European Food Safety Authority (EFSA) to prepare 
comprehensive annual reports on antimicrobial resistance prevalence in animal 
isolates, raw meat isolates and human ones (EFSA and ECDC, 2016). The One Health 
approach has become an inseparable part of antimicrobial resistance surveillance so as 
to match up with surveillance reports, approaches and interventions in human and 
veterinary medicine (Zinsstag et al., 2011). A more further approach is done by the 
Canadian Integrated Program for Antimicrobial Resistance (CIPARS) which proposes 
including the environment, the wildlife, the feed, the companion animals and also 
water and food into their antimicrobial resistance surveillance program (Deckert et al., 
2015). However there are no specific microbial monitoring programs at the retail level 
to determine exposure of consumer to antimicrobial resistant foodborne bacteria. 
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Most food antimicrobial resistance monitoring programs are limited to studies of 
resistance to samples of raw meat (Federal Office of Public Health Foph Division 
Communicable Diseases, 2015; EFSA and ECDC, 2016). The study of foodborne 
microorganisms in the retail sector would greatly help to identify possible transmission 
routes between animal and human microorganisms via food and would further 
improve the strategies for limiting antibiotic resistance in line with the objective of the 
One Health concept (Jans et al, 2018). 
 
Picture 1. Potential routes of transmission of antimicrobial-resistant bacteria via the 
food chain (EFSA, 2008) 
 
Proper use of antibiotics in most sectors, such as agriculture, stockbreeding, 
medicine, would greatly maximize human health benefits by reducing the pace and 
delaying the spread of antibiotic resistant strains. Foods can be contaminated with 
antibiotic-resistant strains during primary production as well as in later stages of the 
supply chain. Contamination of foods of animal origin with resistant bacteria is more 
likely in food from animals that have received antibiotics. However, resistant strains 
can be transmitted to other non-antimicrobial animals. In addition, it has to be known 
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that the resistant strains have the ability to evolve in an external or internal 
environment for long periods of time. Correspondingly, foods of plant origin are likely 
to be contaminated by organic matter such as manure, water, urban sludge containing 
antimicrobial resistant bacteria (Irish Food Authority, 2015). 
Good Agricultural Practice (GAP), Good Hygiene (GHP) and Risk Analysis and 
Critical Control Point (HACCP) procedures are measures aimed at reducing or 
eliminating the antimicrobial resistance of food-producing strains and, in particular, 
eliminating of pathogens and of marker micro-organisms in food. Good practice can 
significantly reduce the risk of AMPB transmission through food. Thus, good hygiene 
during slaughter and skin carcassing can minimize the transport of bacteria, and thus 
also of resistant bacteria. In addition, foods that are adequately cooked, pasteurized or 
are subject to some form of microbicidal treatment, such as high pressure processing, 
are extremely difficult to transport live AMRBs from their early stages of production 
(e.g. primary production). 
In addition to resistant bacteria originating from primary production, there are 
other possibilities to contaminate food. Thus, cooked or processed foods during 
storage, preparation and disposal are likely to become infected with AMRB. In 
addition, drinking water can be a carrier of resistant bacteria, especially when infected 
with fecal (human or animal) strains. Water from drilling on crops or the use of this 
water in food processing as a food ingredient favors the transport of AMRB to food. 
AMR risk management requires monitoring of the use of antibiotics in the food chain 
as well as the occurrence of AMRBs isolated from food and animals. Directive 
2003/99/EC and Commission Implementing Decision 2013/652/EU require monitoring 
of antimicrobial resistance in specific zoonotic pathogens and indicator bacteria 
isolated from food of animal origin and animals. The European Food Safety Authority 
(EFSA) publishes these results every year in EU annual summary reports on 
antimicrobial resistance in zoonotic, animal indicator bacteria and food indicator 
bacteria. The requirements related to AMR monitoring are harmonized for countries 
with regard to methodology, tested microorganisms, sample populations, and 
interpretative criteria (Irish Food Authority, 2015). 
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2.1. Transmission of antimicrobial resistance 
The use of antimicrobial agents in various hosts is the most important factor 
influencing the emergence and spread of antimicrobial resistance by spreading 
resistant bacteria and genes of resistance between hosts not only of the same but also 
of different species (SSC, 1999). Antimicrobials can be dispensed and applied in a 
variety of ways in the human medicine, veterinary medicine and horticultural practice. 
Antimicrobials are used for therapy and prophylaxis against infection. The level of 
supervision is variable since antibiotics are used in certain premises, including hospitals 
and the community (EFSA, 2008). 
 
 
Different types of microorganisms can exchange antimicrobial resistance traits. 
The main pathways by which humans can get contaminated include person-to-person 
transmission, the environment, and contact with animals, including food producing 
and domestic animals. 
Aarestrup (2006) has provided an extensive review of different pathways by 
which AMR bacteria can be transmitted to humans. AMR transmission usually involves 
contamination by AMR bacteria. Therefore good hygienic practices are extremely 
important in order to control and prevent foodborne AMR contamination. 
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Picture 2. Possible transmission of antimicrobial resistance via food (EFSA, 2008) 
 
2.2. Food of plant origin 
Resistant bacteria from various sources can contaminate foods of plant origin. The soil 
is loaded with microorganisms which may harbor antimicrobial resistance genes. Food 
contamination may happen after direct contact of edible portions of plants with soil 
and soil splash. Wastes from animals and human introduced as soil amendments or 
through animal presence provide another pathway for AMR organisms to contaminate 
food of plant origin. Water utilized for irrigation may also be contaminated with AMR 
bacteria. The adoption of good agricultural practices which limit total microbial 
contamination of foods of plant origin is a basic initial phase in diminishing the 
introduction of AMR organisms into food. 
Unfortunately, there are few reagents for treating plants’ bacterial infections. 
Among plant pathogens, antimicrobial resistance is reported for products used in 
treating bacterial diseases e.g. tetracycline, kasugamycin, streptomycin, and copper. In 
respect to antifungals, resistance to fungicides triazole is also relatively common, 
although there seems to have a large variation in the occurrence of resistance 
between different regions. 
P. Gousia  Principles for risk assessment for antimicrobial resistance occurring in the food pathway 
-10- 
There are programs to minimize antimicrobial resistance risks. Biological 
control, with the introduction of organisms providing direct antagonism, competition 
and biorational products, e.g. plant extracts are alternatives that may prevent plant 
diseases. However, these products are generally far less effective (FAO/WHO, 2018). 
2.2.1. Contamination of crops with bacteria resistant to antimicrobials 
The microbiological contamination of fruits, vegetables, lettuce and in general of foods 
of plant origin that are consumed raw or undercooked is responsible for many 
foodborne outbreaks including disease caused by antimicrobial-resistant bacteria. 
Besides, produce at retail may also be contaminated with commensal bacteria that 
carry resistance to medically important antimicrobials (Verraes et al., 2013; Thanner et 
al., 2016). Fungi and bacteria cause worldwide significant plant disease and production 
losses, especially in low- and middle-income countries (LMICs). Climate change is 
possible to exacerbate the problem and the use of antimicrobial agents is expected to 
rise because older treatments become ineffective. There is growing concern that 
antimicrobials are losing their effectiveness in all sectors, not only in horticulture, but 
also in veterinary and human medicine. Extensive use and misuse of antimicrobials 
drives the development and transmission of antimicrobial resistance, but it is unclear 
the extent to which antimicrobial use is driving the development of antimicrobial 
resistance in spoilage organisms, soil organisms, plant pathogens and non-pathogenic 
contaminants and zoonotic agents present on foods of plant origin. Some of the same 
antimicrobial agents that are used in human and veterinary medicine, like 
streptomycin, tetracyclines, triazoles are also used to control plant diseases. 
Consequently, resistance developed in one sector can be transferred across sectors 
and species. Through processes of co-selection and cross-resistance, resistance 
developed to one antimicrobial may also render an organism resistant to several other 
antimicrobial drugs and chemicals. Bacteria, notably zoonotic organisms with 
resistance to one or multiple antimicrobials, are found on fruits, vegetables, and other 
edible plants, as well as in soils. The frequency with which resistant bacteria of plant-
origin colonize the human gastrointestinal tract or serve as reservoirs of antimicrobial 
resistance genes in the gastrointestinal tract needs to be further investigated. There is 
persuading proof that horticultural antimicrobial use is driving the development of 
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antimicrobial resistant fungi that are transmitted increasingly from the environment to 
humans (FAO/WHO, 2018)  
2.3. Food of animal origin and antimicrobial resistance 
2.3.1. Antimicrobial use in food producing animals  
The use of veterinary medicinal products can give rise to risks for human health, food 
safety, the environment, animal health and welfare. In productive animals when there 
is a need for treatment, the use of antimicrobials is an important factor in the 
development of resistance to the microbial population. Treatment should be done 
correctly using the appropriate dosage and administration time. (Geenen et al, 2010) 
2.3.2. Critically important antibiotics in Veterinary medicine  
While WHO created the list of critically important antimicrobial agents, the OIE has 
built up a list in veterinary medicine, that of critically important antimicrobial agents in 
veterinary medicine. The aim of this list is described as “The overlap of critical lists for 
human and veterinary will give additional information, allowing an acceptable balance 
to be struck between animal health requirements and public health 
priorities”(FAO/OIE/WHO, 2004).  
Since the majority of OIE Member States recognized the importance of using 
antibiotics while being considered necessary for certain infections, because of the 
absence of other alternative therapeutic options, it classified a category of antibiotics 
as veterinary critically important drugs. Veterinary Highly Important Antimicrobials 
were antimicrobials when  solely one of the two criteria applies (that is either thought 
important by a majority of the member states of being critically or considered essential 
for the treatment of certain diseases without having equivalent alternatives). The rest  
antimicrobials were classified as veterinary important (OIE, 2007). Antimicrobial 
classes as categorized by the OIE are shown in the following site 
https://www.oie.int/doc/ged/D9840.PDF (Table 2). 
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Table 2. Categorization by the OIE of veterinary important antimicrobials for food-
animals 
Veterinary Critically Important aminoglycosides  
cephalosporins  
macrolides  
penicillins  
phenicols  
quinolones  
sulfonamides  
tetracyclins 
Veterinary Highly Important  rifamycins  
fosfomycinionophores  
lincosamides  
pleuromutilins  
polypeptides 
Veterinary Important bicyclomycin  
fusidic acid  
novobiocin  
orthosomycins  
quinoxalines  
streptogramins 
(ΟΙΕ, 2007) 
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Table 3. Classes and subclasses of antimicrobials classified as critically important for 
human medicine:  
Beta-lactam penicillin, cephalosporin (3rd and 4th generation) 
carbapenem, penem 
Aminoglycoside  
Tetracycline  (tigecycline only) 
Macrolide and ketolide   
Glycopeptide   
Quinolone   
Lipopeptide   
Oxazolidinone   
Streptogramin   
Ansamycin   
(OIE, 2007) 
2.4. Spread of resistance  
Antimicrobial resistance spread between animals and humans may occur by 
transmission of resistant bacteria or by transfer of the antimicrobial resistance genes. 
Resistant bacteria transmitted from animals to humans may cause disease in humans, 
e.g. zoonotic resistant bacteria and pose a direct hazard. Transmission of resistant 
bacteria may occur through direct contact, environmental or food routes. Foodborne 
bacteria of animal origin, that do not cause human disease, but are likely to transfer 
resistance genes to human pathogens are indirect hazard, e.g. horizontal gene 
transfer. 
2.4.1. Mechanisms of gene transfer  
Resistance gene transfer may occur through vertical or horizontal transfer of genes. 
The gene transfer from bacteria to their offspring is known as vertical gene transfer. 
The exchange of genetic material from a bacterium acing as donor to a bacterium-
acting as recipient, but which is not its offspring is known as horizontal transfer of 
genes. The main mechanisms for horizontal gene transfer are: i) conjugation, ii) 
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transduction and iii) transformation. In conjugation, the genetic material is moved 
among bacteria by a temporary linkage between a bacterium donor and recipient 
bacterium. In transduction the genetic material is moved by bacteriophages, and in 
transformation the genetic material is moved by uptake of free DNA.  The most 
frequently reported mechanism of antimicrobial resistance gene transfer is 
conjugation and may take place between bacteria of different species or of different 
genera (EFSA, 2008b). During conjugation, plasmids or transposons can be transferred, 
as mobile genetic elements. Integrons which are gene capture systems found in 
plasmids, chromosomes and transposons and are of considerable importance in the 
dissemination of antimicrobial resistance genetically linked, by capturing, mobilization, 
and expression of resistance genes (Kovalevskaya, 2002). Published gene transfer rates 
during conjugation were found to vary widely (Hunter et al., 2008).  
The dissemination of various resistance genes among different bacterial species 
is due to horizontal gene transfer (Barlow, 2009). Specifically, the gastrointestinal tract 
is a major hot spot for horizontal interspecies and intraspecies gene transfer. 
2.4.2. Transmission via food of animal origin  
Foodstuffs produced from food producing animal pose an important mean for the 
transmission of zoonosis, including resistant zoonotic bacteria, like Salmonella spp and 
Campylobacter spp. Besides, food is potential to conduce to resistance transfer in 
commensal bacteria, as resistance genes are mainly found on mobile genetic 
components. Besides, high numbers of bacteria existing in the gut promote the 
transfer of genes.  
Transmission can happen during consumption or even handling of food contaminated 
with resistant bacteria. Both food handlers as well as the general population can be 
exposed. A possible reservoir may be food handlers themselves and cause foodborne 
diseases among the general population. The extend of consumers’ exposure to 
antimicrobial resistant contaminated food, depends on various factors during food 
processing (Geenen et al, 2010). 
Transmission during slaughter, food processing and food handling: Food can 
become contaminated with resistant bacteria from the faecal material of food-
producing animals or from humans. The main point of dissemination of food animal 
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fecal material is during slaughter. The main point where food becomes contaminated 
with human faeces is during food handling. Therefore, food handling is a common way 
of introducing resistant bacteria into food for bacterial pathogens with a human 
reservoir (CAC, 2001). 
 
Table 4. Food categories of animal origin and transmission pathways (Roberts, 1990) 
Food categories of 
animal origin 
Transmission pathways 
Milk / dairy products Milk is contaminated with bacteria of animal origin and 
human consumes  soft cheeses made of raw milk or raw 
milk  
Egg /  egg products Bacteria are transferred transovarial to egg content and 
human consumes raw or undercooked egg 
Red meat Carcass is contaminated with faecal content during 
slaughtering. Human consumes raw or undercooked 
meat or cross contamination may happen during food 
preparation. 
Poultry meats Carcass is contaminated with faecal content during the 
slaughter process. The consumption of inadequately 
cooked meat or cross contamination during preparation 
food, may happen. 
Fish Aquatic environment is contaminated with faecal 
bacteria and raw fish is consumed. In shell fish, 
concentration of faecal bacteria through filterfeeding, 
Consumers eat raw or inadequately heated shell fish. 
Mixed /  buffet meals Usually one of the previous mentioned pathways and 
consumption of inadequately stored or inadequately 
heated meals happens 
http://ilsi.eu/wp-content/uploads/sites/3/2016/06/MRA-Tools.pdf 
  

P. Gousia  Principles for risk assessment for antimicrobial resistance occurring in the food pathway 
-17- 
3. Risk assessment 
It is widely recognized that risk assessment is as a systemical way to organize and 
analyze information aiming in making regulatory decisions, establishing programs and 
prioritizing research and evolvement (USEPA, 2014). 
3.1. Introduction to Risk Assessment  
In the field of microbiological food safety, significant developments in control 
measures applied to food have been made. Measures and approaches used in food 
safety were based on Good Manufacturing Practice, Good Hygienic Practice, as well as 
on the execution of a Hazard Analysis Critical Control Point (HACCP) system.  
Risk analysis includes “risk management” and “risk communication” as 
associated concepts. Risk assessment occurs within a risk management context, to 
help decision-making on organizing a microbiological hazard and takes into account 
the character of the hazard and the probability of being exposed to that hazard. 
Microbiological risk assessment can vary from a single skilled judgment to a more 
investigative quantitative and qualitative risk assessment (CAC, 1999). The risk 
assessment process according to Codex document lists the following steps in: 
statement of purpose, hazard identification, hazard characterization, exposure 
assessment, risk characterization.  
3.2. Process of Foodborne antimicrobial resistance risk assessment 
The risk assessor should consider, at the beginning, the profile of the risk, the 
documented information during commissioning the risk assessment and the risk 
assessment policy. A preliminary investigation is required to define and organize the 
work to be done within the framework of the foodborne antimicrobial resistance risk 
assessment. Foodborne antimicrobial resistance risk assessment comprises of hazard 
identification, exposure assessment, hazard characterization and risk characterization. 
The second and third phase (exposure assessment and hazard characterization) can be 
done alongside. The choice of a quantitative or qualitative approach is mainly based on 
the type of questions to be answered and also on the available data.  
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Risk assessment is a decision tool that provides risk managers with a logical and 
unbiaesd picture of what is known at a particular time. A risk assessment will not have 
all information given about a certain risk issue due to the fact that there are cases of 
limited access , like unwillingness of data owners to give information or because of lack 
of data (FAO, 2009). Sometimes it is insufficient for the managers to select a strategy, 
due to the fact that the information known at a particular time is insufficient. If the 
criteria for making a decision are well set, a risk assessment based on knowledge at 
that particular time, may provide guidance information to choose the correct decision 
more obviously (FAO, 2009).  
3.3. Antimicrobial resistance risk assessments framework 
As already said, antimicrobial resistance risk assessment is a scientific tool to evaluate 
the health risks (qualitatively or quantitatively) after exposure to resistant 
microorganisms or resistance genes (Geenen et al, 2010). At the beginning of a risk 
assessment, an important step is making a risk management question. That question 
should determine the hazard but also the linked consequences to be investigated, and 
besides other information like the source, the population at risk, the country, the time 
period. The risk question may consist of two parts, the frequency and the 
consequences, for example: 
1. What is the contribution of the use of cephalosporin in broilers in Greece in 2017-2018 
to resistance of E. coli in respiratory infections? 
2. What is the likelihood of adverse effects in human as a sequela of these infections? 
Antimicrobial resistance risk assessment follows a similar four-step framework 
as used in Codex (2009). This framework is mainly established for foodborne 
transmission, but it could also be a guide for risk assessment related to transmission 
through the environment or through direct contact (Geenen et al, 2010). 
3.3.1. Hazard identification 
Hazard identification is the first step, which aims to identify the resistance hazard. But 
what could be a hazard? It could be a resistant bacterium but also a resistance gene 
(Geenen et al, 2010). Risk assessor reviews surveillance programs, literature and other 
information to identify certain strains or genotypes of foodborne bacteria that may be 
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risks by a certain food pathway, resistant to antibiotics microorganism or determinants 
or agents to which resistance is expressed. Besides, the biology of the resistant 
microorganisms or the determinants in various environmental conditions and the 
information on the susceptible strains would be helpful (CAC, 2011). 
Direct and indirect hazards: Foodborne antimicrobial resistance is either a 
direct or an indirect hazard. The direct hazard is the presence on food of antibiotic 
resistant pathogens which may colonize or infect a human, after consuming of 
foodstuffs, or as a hazard arising through handling of contaminated food and the 
person acquires an infection. Indirect hazard happens when a bacterium resistant to 
antibiotics can transfer resistance genes to a pathogen directly, or through another 
commensal bacterium. In the case described above, the resistance gene is the hazard 
(EFSA, 2008; CAC, 2011). 
3.3.2. Exposure assessment 
Exposure assessment is the second step. Exposure assessment recognizes the routes of 
exposure and sums up the data for the certain routes so that it evaluates the 
frequency and the size of the hazard to of human exposure. It should take into 
consideration all reservoirs (humans, pets, food animals, environment etc.), all 
possible routes of the hazard to the population of importance, and, in the case of 
resistance genes, it should be considered the potential transfer of genes to human 
pathogenic bacteria. This poses antimicrobial resistance risk assessment very 
complicated; although the complexity can be decreased by concentrating in the main 
transmission pathways (Geenen et al, 2010).  
Antimicrobial usage happens in various sectors in agriculture and at different 
stages of food supply. Following antimicrobial use, the selection of antimicrobial 
resistant microorganisms may occur, and after, they are able to disseminate among 
animal feed and food animals, or between food animals and sewage , that are going to 
be spread on crops etc (CAC, 2011). 
P. Gousia  Principles for risk assessment for antimicrobial resistance occurring in the food pathway 
-20- 
3.3.3. Hazard characterization  
The aim of the third step, the hazard characterization, is to define the probability of 
the disease as a consistence of the hazard exposure. Antimicrobial risk assessment 
should include the further sequels of resistance, e.g. severity of the disease and 
increased frequency of the disease (Geenen et al, 2010). According to Codex 
Alimentarius, in this step the characteristics of the hazard, the host and the food 
matrix are considered so as to define the probability of human disease. A hazard 
characterization related to foodborne antimicrobial resistance comprises also the 
features of the acquired resistance. It estimates the additional consequences that may 
happen when human is exposed to pathogenic bacteria resistant to antibiotics, such as 
severity and increased frequency of disease (CAC, 2011) 
3.3.4. Risk characterization  
The final step is risk characterization. The results of the previous steps have been 
integrated, in particular and an overall evaluation of risk is derived. Risk 
characterization answers questions containing uncertainties and other agents which 
may influence the risk management decision (Geenen et al, 2010). According to Codex 
Alimentarius (2011), risk characterization is the last step and consults the key findings 
from the previous steps (hazard identification, exposure assessment and hazard 
characterization) to evaluate the risk.  
3.4. Antimicrobial resistance risk assessment methodology 
Antimicrobial resistance risk assessment of foodborne isolates can be either 
quantitative or qualitative, depending on the output expressed, either numerically or 
in qualitative terms. The output’s quality is based on the data availability and quality. 
Most important data limitations in antimicrobial resistance risk assessment are 
microbiological methods used, small sample sizes large variability in sampling 
methods, low compatibility in resistance data and little data on indicator organisms, 
uncertain on reasoning, insufficient data on antibiotic use, lacking test sensitivity or 
specificity. The identification of data gaps is an important output of risk assessment 
which is very helpful in continuing research and collection of data. Limitations of data 
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can be exceeded using expert opinion, substitute data like data on related species 
resistance gene, on susceptible organism of the same species, predictive mathematical 
modelling (Snary et al., 2004).  
In foodborne antimicrobial resistance risk assessment data, there are various 
sources of uncertainty. A helpful tool, by which the effect of uncertainty in the model 
input on the model output can be investigated, is done with sensitivity analysis. Some 
sources of uncertainty mentioned are: the large number of indirect routes, the 
quantification of resistance gene transfer within the animal gut or the human gut, and 
the probable enlarged time period between exposure and infection because of the 
resistance in commensals (Claycamp and Hooberman, 2004). 
3.5. Overview available AMR-risk assessments in the literature 
An overview of the available foodborne antimicrobial resistance risk assessment is 
given in table 5. For the selected hazards, antimicrobial resistance risk assessments are 
only available for quinolone-resistant Campylobacter spp. 
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Table 5. Overview of available AMR risk assessments evaluating the human health risk/source attribution of antimicrobial use in food animals 
concerning Campylobacter resistance (Snary, 2004). 
Resistance 
Food 
animal  Funding 
Qualitative/ 
Quantitative Risk management question Conclusion Reference 
Quinolone Cattle  Industry  Quantitative What is the potential public health 
risk from Campylobacter jejuni and 
fluoroquinolone resistant C. jejuni 
because of fresh beef and ground 
beef consumption? 
After 10 years of fluoroquinolone use in 
beef cattle, 280 individuals and 45 
hospitalized cases need additional 
therapy and/or longer hospitalization, 
and there is one associated death 
(Anderson et 
al., 2001) 
Poultry  Governm
ent  
Quantitative  What is the human health impact of 
fluoroquinolone resistant 
Campylobacter in broilers in 
1998/1999 in the USA? 
In the total population, 1 in 
34,651/26,639 persons were affected; 1 
in 23/17 cases seeking care and 
prescribed an antibiotic were affected 
(Vose et al., 
2001a; 
Bartholomew 
et al., 2005) 
Poultry 
and pigs  
Governm
ent  
Quantitative  What is the contribution of the food 
chain to quinolone resistance in 
microorganisms causing human 
infection relative to other pathways? 
Attribution: exposure abroad (59.6%), 
chicken meat (8%), pets (3.6%), clinical 
treatment (1.5%). Pig meat, public water 
and crop consumption not significant 
(VLA, 2004) 
Macrolide Poultry   Qualitative  What is the risk of transmission of 
macrolide-resistant Campylobacter 
from pigs to man? 
Transmission through pig meat and 
environment (slurry/ waste) has no or a 
very low risk to man 
(Burch, 2002) 
Poultry  Industry  Quantitative  How is food animal illness related to 
human foodborne disease? Example: 
macrolide resistance in 
Campylobacter. 
The removal of macrolide feed additives 
in chickens could harm human health by 
increasing the level of contaminated 
chicken 
(Singer et al., 
2007) 
Poultry, 
pigs and 
cattle  
Governm
ent 
Quantitative  What is the potential human health 
risk due to foodborne Campylobacter 
spp. infections from on-farm use? 
The human health risks due to 
macrolide induced resistance in 
Campylobacter are extremely low.  
(Hurd et al., 
2008) 
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4. Description of the microbiological hazards  
4.1. Direct hazards  
Antibiotic resistant bacteria spread from animals to humans under ordinary conditions 
can cause human disease, known as zoonotic diseases or zoonoses, and results in a 
direct hazard in humans’ health. As mentioned, resistance to antimicrobials can 
decrease the effectiveness of therapeutic treatment of the disease (zoonosis) and 
reduce treatment’s choice. Foodborne resistant strains of zoonotic bacteria may 
elongate the illness’ duration, cause more serious illness, have a higher mortality and 
an increased risk of need of nursing and hospitalization, in comparison to sensitive to 
antibiotics strains (Mølbak, 2005). 
4.2. Indirect hazards  
Antimicrobial usage in food producing animals promotes the development of 
antimicrobial resistance in both pathogenic and non pathogenic bacteria (Varga et al., 
2009). Antimicrobial resistance genes that are carried on mobile genetic elements are 
likely to be transferred to human flora. This can be done by horizontal gene transfer 
during transit (passing) or colonization of the human body (Hunter et al., 2008). 
Consequently, human flora may become resistant, including harmful bacteria to 
humans, like nosocomial pathogen strains (Donskey, 2004). These resistance genes 
thereby act as an indirect hazard. (Geenen et al, 2010) 
4.3. Gene transfer from animals to humans 
The main cause accountable for the dissemination of resistance genes among different 
species of bacteria is horizontal gene transfer (Barlow, 2009). The gastrointestinal tract 
has an important role and is an important place for horizontal gene transfer. This 
horizaontal gene transfer can be achieved interspecies and intraspecies. As 
Enterococcus spp. and Escherichia coli are major residents of the gastrointestinal tract 
of animals, they hold a wide variety of mobile genetic elements. Besides, it is shown 
that these bacteria act as possible donors and accepters of resistance genes (Geenen 
et al, 2010). 
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Resistance gene transfer from a donor bacterium of animal origin and a receiver 
bacterium of human origin has been shown, not only in vitro but also in vivo (De 
Niederhäusern et al., 2004; Lester et al., 2006). 
4.3.1. Examples of agents 
According to data availability, urgency and host-pathogen characteristics, two direct 
hazards and one indirect hazard were selected as examples throughout this risk 
profile. The selected agents are: 
• Campylobacter jejuni quinolone-resistant (direct)  
• MRSA Livestock associated (direct) 
• Bacteria ESBL-producing (indirect) 
4.4. Economic consequences  
Estimated costs derived from antimicrobial resistance are remarkable. Medical costs in 
the USA for the cure of infections caused from resistant strains in high risk hospitalized 
patients were evaluated. The costs ranged from 18,588$ to 29,069$ per patient and 
from 10.7$ to 15.0$ million for the society. (Roberts et al, 2009) 
The cost to the society may be calculated as the cost of illness and should also 
take into consideration the costs for the detection of carriers and the isolation of 
them. Cost of illness comprises of direct costs of healthcare, direct costs of non-
healthcare, indirect costs of healthcare, and indirect costs of non healthcare. Direct 
health care costs are all costs that are directly associated to prevention medicine, 
diagnostic tools, treatment, reconfirmation and patient care. Direct healthcare costs, 
for antimicrobial resistance, should also calculate the costs of screening of group of 
people that are at risk, costs because of positive patients’ isolation, costs of working 
staff tested positive that are non active, costs of outbreak like surgeries and loss of 
hospitalization days. Direct health care costs of resistance may also be costs involved 
to change of empiric therapy and limitation in therapy choices. Direct non-healthcare 
costs are such as travel costs and time of patients, but also include expenses related to 
the patient’s house and non official care (at home) (Geenen at al., 2010). 
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Other consequences of the illness and the treatment which arise are the 
indirect costs. Indirect costs of healthcare are the future economy on health care costs 
due to death at a premature age that most times are not considered (Geenen at al, 
2010). Indirect non-healthcare cost consists of the worth to society of production  that 
is lost because of the absence from work, temporarily or permanently or the longterm 
weakness or infirmity and the precocious mortality as a disease’s consequence. 
4.5. Social consequences 
Antimicrobial resistance on people’s life may have severe impact in some cases but it is 
not  thoroughly studied. Surveys on carriers and patients of Methicilin Resistant 
Staphylococcus aureus (MRSA) in healthcare units show that except from their somatic 
pain, they also suffer from mental health issues, like anxiety, depression, 
stigmatization or socially isolation and usually have fewer social contacts because of 
their fear that they are going to contaminate other people (Donaldson et al., 2007; 
Geenen et al, 2010). 
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5. Assessing the risk of the acquisition of resistant bacteria or resistance 
genes through the food chain 
A trustworthy approach for assessing the risk to human of obtaining resistant bacteria 
or resistance genes via food is required. It is sure that we have a complicated task, 
because of the fact that there are various and many routes of adaptation. Except of 
the food intake, there is also the direct contact with food producing animals, pets, 
environmental exposure, human to human transfer etc. (See previous chapters). 
In this point, we need to focalize only on the pathways of food. Exposure of 
human to resistant bacteria is hard to be measured quantitatively or qualitatively. 
Quantitative details with numbers of resistant to antibiotics bacteria in foodstuffs and 
details on human consumption habits are not available in all cases, and usually they 
are not available so as to input them into a risk assessment. It is not clear if antibiotic 
resistant microorganisms can live through and grow during the food-chain phases, 
such as processing or cooking, to a greater extent in comparison to the susceptible 
bacteria. In addition, in relation to the dose-response characteristics, there are limited 
data if antimicrobial resistant bacteria are more pathogenic or provoke more severe 
disorders in comparison to the non resistant equivalents. Besides, it is difficult to take 
into consideration the significance of transferable genes coding resistance and their 
indirect consequences on human health. Few risk assessments have considered this 
consequence, presumably due to the significant data requirements and, the scientific 
uncertainty connected to within host resistance gene transfer. Many different types of 
consumers exist, that have different consumption habits, like different type of food 
and different quantity of food they consume and also their susceptibility to resistant 
infections varies. An example could be the consumer, who could be an elderly person, 
an adult, a youth or an infant and within each of the above mentioned categories, 
might be also classified as healthy or clinically ill or immunocompromised. 
A risk assessment should also consider a secondary categorization to reveal the 
religious and cultural condition and no compulsory dietary choices such as vegan or 
vegetarian. Similarly, considering the risk of exposure of farmers and their families and 
workers they may eat raw milk or dairy products and besides meat-workers in the 
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meat industry they may eat meat products. Here we can identify many types of 
consumers and we have to consider the potential impact of the different type of 
consumer on their risk of exposure (EFSA, 2008). 
5.1. Issues to be considered: risk assessment applied to antimicrobial resistance 
As already mentioned, risk assessment is a tool. It may be utilized to estimate the 
extend of exposure and the consequent risk to human health because of certain 
bacteria or certain resistance type. Quantitative and qualitative risk assessments both 
have been used to evaluate human’s health risk from resistant bacteria (Snary et al., 
2004). Codex Alimentarius Commission guidelines have available accepted procedures 
(CAC, 1999) for microbiological food safety risk assessments and also for antibiotic 
resistance risk assessment. Besides, the guidelines of OIE, which are more specific to 
risk assessment applied to antimicrobial resistance, are also useful (OIE, 2007a).  
5.1.1. Data requirements for an antimicrobial resistance risk assessment 
Which are the information required that will be determined by the risk analysis 
question? There is no standard data; however, previous data gaps or data deficiencies 
were identified and are summarized in Table 6 (Snary et al., 2004). In the following 
table we can see of the data requirements, gaps/deficiencies. The association between 
antimicrobial use of a certain antibiotic and the emergence and dissemination of 
antibiotic resistance is rarely known and despite many surveys have indicated that the 
antibiotic use is a serious factor for the development of antibiotic resistance, the 
correlation is non-linear. It is also defined by the way the antibiotic is consumed. In this 
manner, on the one side it is indicated that increased dosages may help avoiding the 
selection for the development of resistance to quinolone in Salmonella (Wiuff et al., 
2003), while on the other side, repeated supplemented feeding with tylosin to 
chickens may cause selection for resistant to macrolide C. jejuni, while in contrast 
single treatments may seldom provoke such a condition (Lin et al., 2007). 
  
P. Gousia  Principles for risk assessment for antimicrobial resistance occurring in the food pathway 
-31- 
 
P. Gousia  Principles for risk assessment for antimicrobial resistance occurring in the food pathway 
-32- 
 
5.1.2. Requirements for a risk assessment 
The aim here is i) to identify the extent to which food serves as a source for the 
acquisition, by humans of antimicrobial resistant bacteria or bacteria-borne 
antimicrobial resistance genes; ii) to sort the identified risks and iii) to recognize 
possible control options for decreasing exposure. As a consequence, all agents that 
increase or decrease the risk of human exposure to a certain resistant microorganism 
from of certain origin or source would be taken into account in the wider context of 
the risk assessment. Concretely, the food pathways would conform the “of a farm-to-
consumption” risk assessment and should have the ability to consider the variability of 
production systems and consumer consumption preferences between the different 
countries or areas.  
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(EFSA, 2008) 
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In addition, risk assessments with more details would be performed for the 
other sources of resistant microorganisms and would need to consider the different 
exposures and effects of them referred to the sub-populations of the consumers may 
have. Also, except for the exposure assessment, a total risk assessment should also 
have the need to consider the dose response need for causing infection and the clinical 
illness. In foodborne antimicrobial resistance risk assessment, the consequences on 
the outcome of infection and illness, such as treatment failure, should be included. At 
the end, it should also be considered the risks of direct and indirect transmission of 
genes within human as a host.  
The number of antimicrobial classes should need to be, the bacteria of interest 
such as Salmonella spp., Staphylococcus aureus, Campylobacter spp., shiga toxin 
producing Escherichia coli and the number of potential sources, the degree of 
processing (raw, processed, inadequately processed). So, for the above mentioned 
reasons the assessment presented here is an assessment of the risk of exposure to 
antimicrobial resistant bacteria where food is the vehicle. As long as the assessment is 
designed to be qualitative, however, this is a large and complicated risk question. 
Therefore, a less complex approach to evaluating the extent to which food serves as a 
source is chosen here.  
5.2. Construction of an exposure assessment template: food as a source of 
antimicrobial resistant bacteria.  
5.2.1. Exposure pathway  
The risk pathway begins, in this example, at the point of retail sale. This approach 
allows not including the former stages of production like farms, transport and abattoir. 
This approach is closer to the point of consumption of a food product. Although the 
pathway does not take into consideration the cross-contamination or undercooking of 
food, the prevalence of the resistant bacteria at the sale is used to indicate the 
contamination degree which becomes involved in the restaurant or the home. In this 
example, contamination which may occur following marketplace is not considered.  
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The likelihood of the presence of bacteria in food at retail and besides the 
probability that these bacteria present are also resistant to an antibiotic class can be 
combined, increasingly, to provide an overall probability of the food being 
contaminated with resistant microorganisms at retail. Due to the fact that data on 
food cross contamination and the consequences of preparedness practices of food on 
the viability of resistant microorganisms are rare, as well as dose-response data and 
consequence data, the exposure assessment stops at the point of shopping of the food 
at retail.  
For indicator bacteria carriers of resistance genes, this template can also be 
used. However, the explanation of the results must consider the differences in the 
hazards. This applies comparing the more direct transmission of resistant pathogens 
(macrolide-resistant Campylobacter, fluoroquinolone-resistant Salmonella) to the 
more indirect risk from indicator bacteria (ESBL resistant E. coli and vancomycin 
resistant E. faecium) and besides the indirect risk by pathogens that carry transferable 
resistance genes (Salmonella carrying plasmid mediated ESBL resistance) where gene 
transfer within the human gut must also be considered. For bacteria intentionally 
added to food, such as fermentation bacteria, the same procedure should be applied. 
An integrated assessment of the consequences of exposure to genes spread 
horizontally would be very complex and would require not available. 
Concluding, it should be mentioned that although the adoption of a simplified 
approach makes the risk ranking more feasible, it loses to consider the impact of 
control measures on the risk ranking. Therefore, the potential control options available 
for decreasing exposure may not be included within the risk assessment, but by using 
epidemiological studies or other relevant evidence (EFSA, 2008; IFA, 2015). 
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Picture 3. Example of a risk pathway for assessing the contribution of different foods 
to the occurrence of AMR bacteria in meal components. 
5.2.2. Data requirements and availability 
For each of the data requirements, the number of categories is limited to three or four, 
as it follows. 
5.2.2.1. Probability of bacteria being present in food at retail  
Data are likely to be available for the probability of the bacteria present in food at 
retail, such as prevalence. However, in practice, data quantity and quality will often 
vary. For example, they may vary between large, retail surveys and others carried out 
smaller surveys where the sampling was done not randomized but by convenience. 
Besides, the methods followed may be different between studies and food types.  
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5.2.2.2. Probability that bacteria are present in food at retail and are also 
resistant to antimicrobial class of interest  
Antimicrobial susceptibility tests can also vary. Many studies pick one colony and test 
it for resistance using  non selective culture plates; while others put the colony into 
primary isolation media containing antibiotic. This possibly affects the estimated 
probability of the resistant bacteria present in food. This makes it also difficult to make 
comparisons between studies along with the different food origin. 
5.2.2.3. Probability of antimicrobial resistant bacteria in food at retail 
This probability is simply a multiplication of the two probabilities discussed above. 
There are three categories distinguished: high, >1%; medium, 0.01 - 1 %; low <0.01%. 
5.2.2.4. Probability that food is purchased and prepared for consumption 
The probability of the food being purchased and consumed can be obtained from 
consumption studies, that vary in the level of detail output, different designed purpose 
(nutritional rather than food safety issues). The diverse range of food stuff, the 
different levels of processing must be considered as this affects the risk of the 
consumer exposed to the hazard (consumption data to the level of raw, minimally 
processed and processed).  
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6. Policy overview  
At the international, EU and IS levels, notable policy instruments already exist to tackle 
AMR in, but they are not adequate in addressing the increasing problem of 
antimicrobial resistant bacteria, that are spreading in the environment. Healthcare 
sector should play a primary role in the fight against AMR. Hospitals and health 
systems can take an extensive approach to diminish AMR in humans and the 
environment. This can be achieved by supporting actions that encourage medical 
professionals to safely minimize antibiotic prescription and follow food policies healthy 
and sustainable (Maghear et al. 2017).  
6.1. International level 
Antibiotic resistance is worldwide problem due to human mobility and trade of food 
and animals; it is a problem that crosses national borders. Antibiotics’ overuse and as 
consequent antibiotic resistance in one region will frustrate achievements in AMR 
elsewhere (Nathan and Cars, 2014). For that purpose, countries must focus to the 
spread of AMR and international and collaborative action is needed. 
In 2009 the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was 
established, for future collaborations between the U.S. and the EU as to increase 
information exchange, understand new practices and best approaches, as well as 
develop premier relationships (CDC, 2016). To deal with the challenge of antimicrobial 
resistance at the international level and to achieve the goal settings of the Global 
Action Plan on Antimicrobial Resistance, the World Health Organization in 
collaboration with the Food and Agriculture Organization and the World Organization 
for Animal Health, has published multiple global strategies for antimicrobial resistance 
(AMR). This Global Action Plan aims to ensure the continuity of the ability to treat and 
prevent infectious diseases with the use of effective and safe medicines. WHO has also 
created and continues to update, a list of medically important antibiotics, to manage 
the arising risk from antibiotic use in agriculture. Besides, WHO provides guidance on 
surveillance of antibiotic resistance and antibiotic use (WHO, 2017; WHO, 2018). 
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The OIE has also lots of activities linked to antimicrobial resistance. A global 
survey of veterinary antibiotics use and a list of sales of antibiotics important for 
animal agriculture (OIE, 2015; OIE, 2018). Other OIE surveys are available online for: i) 
improving general and political awareness of AMR, ii) promoting better practices in 
food and agricultural systems, and iii) ensuring judicious use of antibiotics to help 
battle AMR (Maghear et al, 2009. According to the FAO’s Code of Practice to Minimize 
and Contain Antimicrobial Resistance, this risk management will be performed with 
respect of a ‘One Health Approach’ (FAO, 2005). This Code of Practice focuses on 
antimicrobial use in food animals and recognizes that antimicrobial resistance is also 
an ecological problem. The One Health concept is an approach implementing policies, 
programs, research and legislation, in which different and multiple sectors work 
together and collaborate to achieve better public health outcomes (WHO, 2017b). 
6.2. European Union level; the role of EFSA in AMR 
The European Food Safety Authority (EFSA) is an agency funded by the EU that acts as 
scientific advice and communication source on risks related to the food chain. EFSA is 
actively involved in several activities within the space of antimicrobial resistance 
(AMR). It provides scientific recommendation used to support the European legislator 
and Member States in creating effective and timely risk management choices in 
tackling AMR for example, in reducing the need to use antimicrobials in food-
producing animals or in managing emerging threats such as resistance of bacteria to 
beta-lactams, colistin and carbapenems. EFSA provides advice on how to monitor 
antimicrobial resistance in food and food animals and gathers and analyzes data 
collected at the national level in Europe. Finally, it actively communicates the risks 
connected to antimicrobial resistance.  
6.2.1. Scientific advice to the risk manager; scientific advice and AMR risk assessments 
EFSA is providing with scientific and technical advice on AMR regulators, as a basis of 
informing related risk management decisions. Over recent years, EFSA has been 
consulted by the European Commission on a variety of topics and has taken the 
initiative to analyze and investigate AMR related emerging risks of particular concern 
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for food safety and public health. For instance, scientific opinions were adopted by the 
EFSA Panel on Biological Hazards (BIOHAZ Panel) on MRSA (EFSA, 2009), ESBL-/AmpC 
producing and carbapenemase-producing bacteria in food animals and food (EFSA, 
2011; EFSA, 2013). The AMR data collected may additionally be useful once 
investigating the effectiveness of management measures taken or the final impact of 
an AMR local / national action plan and efforts towards the reduction of AMC and AMR 
in both humans and. Animals. 
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7. How can we act now? 
The magnitude of the matter is currently accepted. Even today, 700,000 individuals die 
of resistant infections each year. We tend to estimate that by 2050, ten million lives a 
year and an additive one hundred trillion USD of economic output are in danger 
because of the increase of drug resistant infections, if we tend not to realize proactive 
solutions currently to block the increase of drug resistance. Antibiotics are a special 
class of antimicrobial medicine that underpins modern medication as we all known: if 
they lose their effectiveness, key medical procedures (such as gut surgery, caesarean 
sections, joint replacements, and therapy that depress the immune system, like 
chemotherapy) might become too dangerous to perform. Most of the direct and far of 
the indirect impact of AMR can fall on low and middle-income countries. 
To stop the worldwide rise of drug-resistant infections, there's a demand issue 
that must be mounted. The supply of latest medicines is lean to stay up with the rise in 
drug resistance as older medicines are used a lot of wide and microbes evolved to 
resist them. At the identical time, the demand for these medicines is incredibly badly 
managed: huge quantities of antimicrobials, specifically antibiotics, are wasted globally 
on patients and animals. A change is needed within the manner that antibiotics are 
consumed and prescribed, to preserve the quality of existing drugs for extended and to 
scale back the urgency of discovering new ones. Governments ought to be control 
responsible on this goal to scale back the demand for antimicrobials and specifically 
antibiotics, as ought to the most sectors that drive antibiotic consumption: aid 
systems, the pharmaceutical companies and also the farming and food production 
industry. 
The main steps to reduce demand are the following:  
1. A worldwide public awareness campaign. We need to boost world awareness of 
AMR across the board, so patients and farmers don't demand, and clinicians and 
veterinarians do not prescribe antibiotics once they are not required. So, policy 
manufacturers make sure that policies to tackle AMR are taken forward. The 
value of running a sustained public awareness campaign across the globe would 
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depend upon its nature and scope. Based on estimates it might cost between 
forty and one hundred million USD a year.  
2. Improving hygiene and sanitation and prevent the spread of bacteria. 
Improving hygiene and sanitation was essential in the 19th century to counter 
infectious diseases. Two centuries later, this is often still true and is additionally 
crucial to reducing the increase in drug resistance: the fewer individuals get 
infected, the less they have to use medicines like antibiotics, and also the less 
drug resistance arises. All countries have to act. Some within the developing 
world can have to specialize in rising the fundamentals 1st, by increasing access 
to wash water and sanitation. For alternative countries the main target are to 
scale back infections in health and care settings, like limiting superbugs in 
hospitals. The best manner that each one people will facilitate counter the spread 
of infections is by correct hand washing. 
3. Reduce unnecessary use of antimicrobials in agriculture and their dissemination 
into the environment. In agriculture and aquaculture, there are circumstances 
where antibiotics are required to maintain animal welfare and food security. 
However, very often their global use is not for treating sick animals, but rather 
to forestall infections or just as growth promoters. The quantity of antibiotics 
used in livestock is large. In the US, for instance, of the antibiotics outlined as 
medically vital for humans by the North American nation Food and Drug 
Administration (FDA), over 70 % (by weight) are sold-out to be used in animals. 
Several countries are possible to use a lot of antibiotics in agriculture than in 
humans, however they do not publish the data. Most of scientists see this as a 
threat to human health, on condition that wide-scale use of antibiotics 
encourages the problem of resistance, which might unfold to have an effect on 
humans and animals alike. We tend to propose three steps to boost this case. 
First, 10-year targets to scale back supererogatory antibiotic use in agriculture, 
introduced in 2018 with milestones to support progress according to countries’ 
economic development. For this to succeed, governments should support and 
speed up current efforts, as well as those of the globe Organization for Animal 
Health (OIE) et al., to live antibiotic use and farming practices. Second, 
restrictions on bound kinds of critically important antibiotics. Several antibiotics 
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that are currently last-line in medicine for humans are getting used in 
agriculture; action ought to be taken on this desperately by a world panel. 
Third, we have to improve transparency from food producers on the antibiotics 
used to raise the meat that we eat, to modify consumers to create more 
informed purchase selections. Antibiotics will reach the environment in various 
ways like through sewage systems (also from hospitals) and run-off from food-
producing units like farms and may then create potential issues for AMR. One 
area that has not received enough focus thus far is the way that the active 
ingredients for antibiotics are manufactured and notably the impact of effluent 
from factories on AMR in close water systems. (supply chains). To tackle this, 
we need regulators to line minimum standards for the treatment and release of 
producing waste; and also manufactures to drive higher standards through 
their supply chains. Both of them should take responsibility and proper this 
supererogatory environmental pollution straightaway. 
4. Improve worldwide surveillance of antimicrobial resistance and anibiotic 
consumption in humans and animals. Surveillance is one amongst the 
cornerstones of infectious disease management, nonetheless, has till recently 
been typically ignored and remains under-resourced within the fight against 
AMR. After Ebola, countries have begun to increase funding during this area 
recently, specifically the US Government via the Global Health Security Agenda 
(GHSA), the United Kingdom government with its announcement last years of 
the 375 million USD Fleming Fund and also the World Health Organization 
(WHO) with its developing Global AMR Surveillance System (GLASS). With 
oversight from the WHO, governments should build on these efforts to collect 
data about the consumption of antimicrobials, the levels of resistance, and the 
underlying biological reasons for resistance, supporting countries that need it 
most in doing so. They must also put systems in place now that will make the 
most out of the ‘big data’ on drug resistance that will be generated on an 
unprecedented scale as diagnostic tools are modernized, and cloud computing 
is embraced.  
5. Promote rapid new diagnostics to reduce unnecessary use of antimicrobials. 
Rapid diagnostics could transform the way we use antimicrobials in humans 
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and animals: reducing unnecessary use, slowing AMR and so making existing 
drugs last longer. It is not acceptable that much of the technology used to 
inform the prescription of important medicines like antibiotics has not evolved 
substantially in more than 140 years. Rich countries must lead the way to 
change this: they should make it mandatory that by 2020 the prescription of 
antibiotics will need to be informed by data and testing technology wherever 
available and effective in informing the doctor’s judgement to prescribe. This 
will spur investment by giving diagnostics developers the assurance that 
effective tests will be used. Our proposed Global Innovation Fund for AMR 
would support early-stage research in this area. In low and middle-income 
countries where access and affordability are the main barriers, a diagnostic 
market stimulus would provide top-up payments when diagnostics are 
purchased, in a similar way that setting up Gavi, the Vaccine Alliance, in the 
early 2000’s revolutionized global vaccine coverage in what was one of the best 
returns on investment to support economic development and wellbeing. 
6. Promote development of vaccines and alternatives. Vaccines can prevent 
infections and therefore lower the demand for therapeutic treatments, 
reducing use of antimicrobials and so slowing the rise of drug resistance.  
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8. Conclusions 
Microbiological  risk  assessments  mostly  focus  on  evaluating  human adverse  health  
risks  from  exposures  to  pathogenic  microorganisms.  Risk assessment is a decision 
tool that gives risk managers an objective picture of what is known at a particular time. 
Limited access to all relevant information or lack of data make risk assessments more 
difficult. What is known at a certain time is not sufficient for a risk manager in the 
selection of a strategy. When the criteria of a risk manager for making a decision are 
well defined; a risk assessment based on current information provides guidance to 
make the choice of a correct decision. 
Foodborne antimicrobial resistance risk assessment is a process to evaluate 
qualitatively or quantitatively the health risks after exposure to resistant to antibiotics 
bacteria or resistance genes, in the food pathway. Hazard could be a resistant 
bacterium as well as a resistance gene in the food chain. Foodborne antimicrobial 
resistance is addressed either as a direct or an indirect hazard, through resistance 
transfer. The direct hazard is the presence in food of resistant to antibiotics pathogenic 
bacteria which have the ability to colonize or infect a human, after ingestion of the 
food, or as a hazard that arises through handling contaminated food and the person 
acquires an infection. Indirect hazard happens when a bacterium resistant to 
antibiotics may transfer resistance genes to a bacterium pathogenic for humans, 
directly, or via another commensal bacterium. In this case, the hazard is the resistance 
gene. 
Antimicrobial resistance has increased in bacterial pathogens worldwide 
leading to treatment failures in human infectious diseases. Resistance pathogenic 
bacteria are of major concern. Bacteria are able to adapt speedily to new 
environmental conditions like the presence of antibiotic molecules and consequently 
antimicrobial resistance may occur with increasing exposure to antimicrobials. Major 
concerns about antibiotic resistance in bacteria isolated not only from hospitals, but 
also from community and food products, have been raised at national but also at 
international levels. 
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As an effort to battle with the complexity of resistance selection, the transfer 
through the food chain, and the consequences in human’s health, risk assessments are 
now being applied. Risk assessments have been conducted for many antibiotics used in 
food producing animals and the estimated risk to human health is determined. Risk 
management strategies implemented to minimize antibiotic resistant foodborne 
bacteria along the food chain must be improved. These new strategies must  include 
the use of drugs alternatives to antibiotics, implementation of prudent use of 
antibiotics and implementation of national antimicrobial resistance monitoring 
programs. 
Although nowadays we have much emerging knowledge about antimicrobial 
resistance and will definitely help us built improved quantitative or qualitative 
antimicrobial resistance risk assessments, the immediate need is to characterize the 
health consequences on human health from foodborne antimicrobial resistance, 
according to the author. Steps taken by Public health and food sectors and also by 
research groups toward improved data for risk assessments include the development 
of epidemiological surveillance networks (NARMS, EFSA/ECDC/EMA). In the past 
databases reported large-scale epidemiological findings on resistant strains and 
resistance frequencies. Other data are needed to improve estimation for resistance 
reservoirs that may occur in the food pathway. Nowadays, the interest of public health 
agencies in the impact of risk management strategies in reducing antimicrobial 
resistance has fostered development of surveillance databases. This is absolutely 
necessary, due to the fact that even today, 700,000 individuals die of resistant 
infections each year. We tend to estimate that by 2050, ten million lives a year and an 
additive one hundred trillion USD of economic output are in danger because of the 
increase of drug resistant infections, if we tend not to realize proactive solutions 
currently to block the increase of drug resistance. Besides, the estimated costs of 
antimicrobial resistance are considerable. Calculated medical costs in the USA for the 
cure of infections with antimicrobial resistant strains in high-risk hospitalized patients 
ranged from $18,588 to $29,069 per patient. In parallel, social consequences on 
everyday people’s life may also be severe. Studies on patients and carriers in 
healthcare units show that except from their somatic pain, they also suffered from 
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psychological problems, such as anxiety, depression, stigmatization due to the fear of 
contaminating people. 
These are the trends. Everyone has to think how he can act today! 
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